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13 Ethinyl oestradiol in the aquatic 
environment
  
Many decades of research have shown that when released to the environment, a group of 
hormones known as oestrogens, both synthetic and naturally occurring, can have serious 
impacts on wildlife. This includes the development of intersex characteristics in male fish, which 
diminishes fertility and fecundity. Although often sublethal, such impacts may be permanent and 
irreversible. 
This chapter describes the scientific evidence and regulatory debates concerning one of these 
oestrogens, ethinyloestradiol (EE2), an active ingredient in the birth control pill. First developed 
in 1938, it is released to the aquatic environment via wastewater treatment plants. Although it is 
now clear that wildlife species are exposed to and impacted by a cocktail of endocrine disrupting 
chemicals, there is also reasonable scientific certainty that EE2 plays a significant role, and at 
vanishingly low levels in the environment. 
In 2004 the Environment Agency of England and Wales accepted this, judging the evidence 
sufficient to warrant consideration of risk management. In 2012, nearly 75 years after its 
synthesis, the European Commission proposed to regulate EE2 as a EU-wide 'priority substance' 
under the Water Framework Directive (the primary legislation for protecting and conserving 
European water bodies). This proposal was subsequently amended, delaying any decision on a 
regulatory 'environmental quality standard' until at least 2016.
This is in part because control of EE2 will come at a significant price. Complying with proposed 
regulatory limits in the environment means removing very low (part per trillion) levels of EE2 
from wastewater effluents at considerable expense. 
Is	this	a	price	we	are	willing	to	pay?	Or	will	the	price	of	precautionary	action	be	simply	too	
high — a pill too bitter to swallow? To what extent is society, which has enjoyed decades of 
flexible fertility and will also ultimately pay for the control and management of its unintended 
consequences, involved in this decision? And what could this mean for the many thousands 
of other pharmaceuticals that ubiquitously infiltrate our environment and which could have 
sublethal effects on aquatic animals at similarly low levels?
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13�1 Introduction
A large body of scientific data built up over many 
decades indicates a cause‑effect link between 
exposure to a complex cocktail of chemicals and 
the feminisation and demasculinisation of wildlife 
species, particularly those living in or around the 
aquatic environment (reviewed in Lyons, 2008). 
Some scientists also relate exposure to hormonally 
active chemicals (so‑called 'endocrine disruptors', 
including alkylphenols, bisphenol‑A, phthalates, 
flame retardants and many other chemicals in 
everyday use) to declining sperm counts, increased 
incidence of male genital abnormalities, testicular, 
breast and prostate cancer in human populations 
(Lyons, 2008; Sharpe, 2009), breast growth in young 
men (Henley et al., 2007), and early onset of puberty 
in young girls (Den Hond and Schoeters, 2006; 
Jacobson‑Dickman and Lee, 2009). 
Over the last 50 years, since the publication of 
Silent Spring by Rachel Carson in 1962, we have 
learned that chemicals in food, household products, 
medicines and cosmetics, can be and are harmful to 
wildlife at very low levels. Many of these chemicals, 
each present at vanishingly low (parts per trillion) 
concentrations, can together have additive biological 
effects — producing 'something from nothing' in 
the words of Silva et al. (2002). Awareness of this 
reality has awoken scientists and the public to an era 
of possible harms from low‑level, chronic chemical 
pollution (e.g. from human pharmaceuticals). 
These chemicals may not have obvious catastrophic 
effects such as those observed for the endocrine 
disrupting anti‑foulant tributyltin (TBT), which 
devastated commercially important oyster 
populations (see EEA, 2001, Ch. 13 on TBT and Gee, 
2006). They can, however, have less obvious effects 
that nonetheless cause irreversible harm to individual 
organisms. This raises difficult questions concerning 
the relationship between these damaging but 
sub‑lethal impacts on wildlife and their connections 
to ecological (e.g. population level) impacts, 
and to human health. It also raises issues for the 
precautionary principle, which states that where there 
is evidence of damage and irreversible harm, lack 
of full scientific certainty should not excuse inaction 
(UN, 1992). As we shall describe, the evidence 
suggests that it is entirely reasonable to invoke the 
precautionary principle and introduce regulation to 
limit aquatic exposure to EE2. But this is no trivial 
matter, and the reasons for this raise serious questions 
for the precautionary principle itself.
This is the story of one of these chemical pollutants, 
the	contraceptive	pill	hormone	17α-ethinyloestradiol	
(EE2) as it has unfolded in the United Kingdom 
from the 1970s to today
13.1.1 The contraceptive pill
The first orally active synthetic steroidal oestrogen, 
EE2 (1), was synthesised by Hans Herloff Inhoffen 
and Walter Hohlweg at Schering AG in Berlin 
(Inhoffen and Hohlweg, 1938; Maisel, 1965) in 1938. 
EE2 was invented at a time when scientists across 
the world were intensifying their research into sex 
hormones as a means of controlling fertility and 
gynecological disorders. They were inspired by the 
remarkable successes achieved during the 1920s in 
using insulin to treat diabetes, thyroxine to alleviate 
thyroid deficiencies and metabolic disorders, and 
by the discovery of progesterone, the ovulation 
preventing hormone in 1934 (Sneader, 1985). 
At a similar time, Edward Charles Dodds, a 
British medical researcher, discovered the potent 
oestrogenic properties of diethylstilbesterol 
(Dodds et al., 1938; EEA, 2001, Ch. 8) and those 
of bisphenol‑A and 4‑nonylphenol (Dodds et al., 
1936), now well known endocrine disrupting 
chemicals. While BPA (see Chapter 10 on BPA) 
and 4‑nonylphenol never found uses as drugs 
(their future was to be in plastics and detergents, 
respectively), for many medical practitioners and 
scientists there seemed no limit to the extent to 
which artificial oestrogens could be put to good 
medical use. EE2 was first marketed by Schering 
as Estinyl in 1943 and initially used to manage 
menopausal symptoms and female hypogonadism. 
It appeared to be readily absorbed orally and very 
resistant to degradation and metabolism by the gut. 
The stability and effects of EE2 paved the way for 
developing oral contraceptive pills ('the pill'), which 
eventually occurred in the 1950s and 1960s (Medical 
News, 1961). 
The development of the pill was powerfully 
intertwined both with concerns about 
overpopulation and the 'sexual revolution' of the 
1960s. Symbolically, it was much more than a tool 
for contraception. From the start it was linked with 
the hopes that it could curb population growth 
and bring about world stability. The first version 
of the contraceptive pill (Enovid) contained the 
hormones mestranol (the methyl ether of ethinyl 
oestradiol) and norethynodrel (a progesterone‑like 
(1)	 17α-ethinyloestradiol	is	the	17α-ethinyl	analogue	of	the	natural	female	hormone,	17β-oestradiol.	
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hormone). As Dr John Rock, a catholic obstetrician‑
gynecologist who ran some of the first clinical trials 
of the birth control pill, noted in 1967, 'If taken as 
it should be … it will stop ovulation 100 per cent' 
(CBC digital Archives, 1964). 
Today the mechanisms of action of synthetic 
oestrogens and progestogens (2) are well 
understood. They are taken up by the cells in 
the reproductive system, pituitary, bone, liver 
and other tissues and bind to oestrogen and 
progesterone receptors, triggering increases or 
decreases in the expression of genes regulated 
by these hormones, in turn controlling gender, 
sexual development and reproduction. When taken 
correctly in the contraceptive pill, they interfere 
with the normal monthly cycle of a woman, 
preventing pregnancy by stopping the ovaries from 
releasing an egg, making it difficult for sperm to 
enter the womb (by thickening mucus in the cervix) 
and making the lining of the womb too thin for a 
fertilised egg to implant. 
The American Food and Drug Administration 
approved the pill for use in the US in early 1961 
and on 4 December 1961, Enoch Powell, then 
Minister of Health, announced that it could be 
prescribed through the UK National Health Service 
at a subsidised price of two shillings per month 
(Time, 1961). Take up of the pill was fast. Between 
1962 and 1969, the number of UK users rose from 
approximately 50 000 to one million (out of an 
estimated 10 million users worldwide), generating 
an enormous social impact and earning it a place 
on the front cover of Time Magazine in April 1967 
(Time, 1967) (3). The pill is hailed as playing a 
major role in the women's liberation movement 
and greater sexual freedom (Asbell, 1995; Goldin 
and Katz, 2002). Its availability, particularly in 
the developed world, has made a significant 
and dramatic impact on women's lives: giving 
unprecedented control over fertility, preventing 
pregnancy, and so avoiding the mortality and 
morbidity associated with pregnancy, childbirth 
and termination. 
The pill now comes in 32 different forms and is 
used by more than 100 million women worldwide. 
Usage varies widely by country (UNPD, 2006; 
Leridon, 2006), age, education, and marital status. 
One quarter of women aged 16–49 in Great Britain 
currently use the pill — either the combined pill, 
progesterone‑only pill or 'minipill' (Taylor et al., 
2006) — compared to only 3 % of women in Japan 
(Hayashi, 2004; Hayes, 2009), which, in 1999, 
became the last country in the developed world to 
legalise the pill.
13.1.2 Evidence of environmental harm from 'the 
pill'
In the 1970s some scientists began speculating 
that using the contraceptive pill might cause 
environmental problems (e.g. Tabak and Bunch, 
1970). They realised that oral medications, 
including contraceptives, are in fact rather 
inefficient methods for administering drugs to 
the body, since it takes a lot of drug administered 
orally to get a little into the bloodstream. The 
rest of the medicine passes right through the 
body and into wastewater in urine and faeces. 
Since water and waste treatment plants were 
not designed to remove pharmaceuticals (or 
indeed other man‑made chemicals), it was likely 
that the contents of our medicine cabinets were 
unintentionally being passed on directly into the 
environment, and eventually, even into drinking 
water supplies. 
EE2 is excreted as conjugates of sulphates 
and glucuronides, along with the natural 
steroid hormones oestrogens oestrone (E1), 
17β-oestradiol(E2)	and	oestriol(E3)	that	occur	
naturally in humans. The synthetic EE2 shares 
a common hormonal mode of action with these 
natural oestrogens, which also means that, when 
released into the environment, the oestrogenic 
endocrine disrupting effects of EE2, and the natural 
steroid oestrogens in combination are additive. 
EE2, the synthetic oestrogen, is however by far the 
most potent of the four.
The data supporting the need for risk management 
of EE2 and the most potent of the three other 
steroid oestrogens (E2 and E1), due to their 
endocrine disrupting effects in the environment, 
are now comprehensive and compelling (Gross‑
Sorokin et al., 2006; Caldwell et al., 2008). 
Based on data amassed over many decades, the 
mechanism of toxicity of EE2, E2 and E1 is now 
well understood. They are continuously, and 
widely, released into the aquatic environment 
and are persistently present, having a half life 
in fresh water of between less than a day and 
approximately 50 days under aerobic conditions. 
(2) Progestogens (also spelled progestagens or gestagens) are a group of hormones including progesterone.
(3) Front cover of Time Magazine's April 1967 edition can be viewed at: http://www.time.com/time/covers/0,16641,19670407,00.html.
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They have been shown to cause endocrine 
disrupting effects at environmentally relevant 
concentrations in controlled laboratory studies 
(e.g. Lange et al., 2001; Nash et al., 2004, reviewed 
in Caldwell et al., 2008), in field studies of fish 
placed downstream of sewage treatment works 
with various types of secondary treatment 
technologies (Harries et al., 1996 and 1997) and in 
whole experimental lake studies dosed with EE2 
(Kidd et al., 2007). 
In some UK rivers, 100 % of wild male fish of the 
species Rutilus rutilus (roach, a common freshwater 
fish of significance to anglers) sampled between 
1995 and 2002 had female characteristics (Jobling 
et al., 1998) and intersex has now been reported in 
many fish of a number of freshwater and marine 
species, in more than 10 countries (Tyler and 
Jobling, 2008; Hinck et al., 2009). Models predicting 
exposure of riverine fish to EE2, E2 and E1 in the 
United Kingdom have also been shown to correlate 
well with impacts observed in fish populations 
in the field (Jobling et al., 2006). These impacts 
damage fish reproductive health, for example 
affecting fertility and fecundity (Jobling et al., 
2002a and 2002b; Harries, Hamilton et al., 2011) 
and are in some cases irreversible (Rodgers‑Gray 
et al., 2001). 
Risk characterisation of EE2 and the other two 
non‑synthetic steroid oestrogens, E2 and E1, 
in the aquatic environment is possibly one 
of the most comprehensive for any chemical 
pollutant. Many millions of euro have been 
spent on this research over many decades. The 
chemical industry has concluded that 'endocrine 
disruption is undoubtedly occurring in wild fish 
populations' and that the evidence that wildlife 
has been impacted adversely following exposure 
to endocrine disrupting substances is 'extensive' 
(Webb et al., 2003). The pharmaceutical industry, in 
particular, has carried out and funded some of the 
key lab studies showing that EE2 plays a key role 
in causing these effects (e.g. Lange et al., 2001). 
In response to this evidence, in 2004 the 
Environment Agency of England and Wales (EA) 
concluded that risk management was needed for 
steroid oestrogens (Gross‑Sorokin et al., 2006). In 
2012 the European Commission proposed EE2 as 
a Priority Substance (i.e. a substance requiring 
control across Europe) under the Water Framework 
Directive, one of the most important pieces of 
legislation for protecting European surface and 
ground waters, proposing regulatory limits in 
the aquatic environment for EE2. At present, 
this is only a proposal, with formal processes of 
agreement required before regulation can occur. 
In July 2012 an amendment to this proposal was 
tabled. This delays review of a proposal for a 
regulatory limit until 2016 (rather than 2012), 
which (if adopted) would then have to be complied 
with by 2027. Nevertheless nearly 75 years after its 
initial development, during which time some of the 
most comprehensive and compelling evidence of 
environmental impact for any chemical has been 
amassed, a decision to regulate of EE2 is finally 
under serious consideration. Why has this taken so 
long? And what lessons can we learn?
The example of EE2 and endocrine disruption in 
the aquatic environment, and the questions and 
dilemmas it raises, is in many ways a test case 
for many thousands of low‑level pollutants that 
infiltrate our environment ubiquitously, many of 
which have chronic impacts that go beyond the 
acute polluting effects of past industrial chemicals. 
13�2 Early warnings
13.2.1 Early warnings from wildlife: 
the UK experience
The earliest concerns about possible hormone 
contamination of water (from contraceptive pills 
and other sources) related to impacts on male fish 
reproductive health in UK rivers. In 1978, Tony 
Dearsley, a Thames water area biologist in the 
United Kingdom, found eggs developing in the 
testes of five out of 26 male fish of the commonly 
caught species Rutilus rutilus (the roach) while 
conducting a routine health check on a small 
sample of fish from the River Lea. 
As Dearsley's manager, Roger Sweeting, then 
Senior Scientist at Thames Water, noted, 'It was 
amazing to see macroscopically hermaphrodite 
fish that were both male and female all at the same 
time'(Sweeting, pers. comm.). It was not until 
a year later, however, after reading a paper by 
Jafri and Ensor (1979), that Sweeting telephoned 
David Ensor, who confirmed that the findings 
were highly unusual. Jafri and Ensor had reported 
a normal incidence of hermaphroditism of 1 in 
1 000, in the same species of fish (Jafri and Ensor, 
1979), more than 100 times lower than found in 
the fish collected from the Lower River Lea (see 
Figure 13.1). 
Larger samples of fish confirmed the earlier 
observations. It was also observed that the 
incidence of feminisation varied with the age of 
the fish, with the highest proportion (20 %) found 
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in the older fish (aged more than six years). Roger 
Sweeting reported that this suggested a 'cumulative 
effect with time' (Sweeting, 1981).
Thames Water, at the time a government‑owned 
company, was proactive in researching the 
matter further to gain a better understanding of 
its relevance to public health. It was reasoned 
that 'some risk of endocrine disturbance in 
human consumers of the water could be implied' 
(Sweeting, 1981) as it was known that the River 
Thames received discharges from numerous 
wastewater treatment plants (352 according to 
Williams et al. (2008)) and that it also served as 
a major potable water source for North London. 
Water abstracted from the river was purified, used 
by people, or industry, and then disposed of to 
sewage treatment works, where it was 'cleaned' 
before being discharged (as effluent) back into the 
river, only to be abstracted, used and cleaned a 
second or subsequent time downstream. (For this 
reason, it is a commonly said that when you drink 
a glass of water in London, the water has already 
passed through several pairs of kidneys). 
Thames Water's concerns for public health led 
to further studies (never published) under a 
research contract given to Liverpool University. 
Water samples were taken directly from the River 
Lea at the drinking water abstraction point and 
transported on a train to Liverpool University, 
where they were given to rats to drink. Derek 
Tinsley (a PhD student at the time who now works 
for the Environment Agency of England and Wales) 
recalls visiting the station at regular intervals to 
collect the water. The studies showed clearly that 
giving female rats this water to drink for 12 months 
induced persistent oestrous.
Further studies showed, however, that water 
samples taken part way through the drinking 
water treatment process had no effects on the rats. 
Moreover autopsies of small mammals (water 
voles and wild rats) trapped around the sewage 
works revealed no obvious gross reproductive 
abnormalities. Derek Tinsley recalls that he felt 
'relief that there were no signs of any effects of 
the treated drinking water on the rat reproductive 
system, and therefore no apparent risks to the 
consumer' (4). 
Thames Water officials felt confident enough to 
present Tinsley and Ensor's results to a standing 
committee of the Department of Health, which, 
after conducting further studies, agreed that there 
was enough information to discount any possibility 
of risk to human consumers of water abstracted 
from the Lower Lea. It is striking that such a rapid 
decision was made on the basis of this small set of 
studies. This, as we will go on to discuss, is in stark 
contrast to decision‑making regarding protection 
of aquatic wildlife from the effects of EE2 and other 
oestrogens, despite the many studies indicating 
adverse health effects related to oestrogen exposure.
The possibility that the contraceptive pill hormone 
might well be causing intersex in fish was not 
formally stated in any of the scientific reports 
circulated between the government and the water 
industry. Nor was any link made with the reports 
of occurrence of steroidal oestrogens in wastewater, 
river and potable waters (Tabak and Bunch, 1970; 
(4) Personal communication from Derek Tinsley.
Note: Image (1) shows a female-like ovarian cavity in an otherwise normal testis. Image (2) shows a severely intersex gonad 
following	exposure	to	sewage	effluent	with	a	testis	containing	a	large	number	of	primary	oocytes	at	a	single	focus.	
Image	(3)	shows	the	intersex	gonad	of	a	wild	fish	caught	from	the	River	Aire,	the	United	Kingdom.	Tl	denotes	'testis	lobule'.	
PO	denotes	'primary	oocyte'.
Figure 13�1 Histological sections showing intersex phenotypes in roach
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Tabak et al., 1981; Aherne et al., 1985). At least 
one of those studies had recognised that steroidal 
oestrogens could potentially have adverse effects, 
even if none were identified:
'the concentrations found are far below 
therapeutic doses and there appears to be 
no evidence of adverse effects from reused 
water resources which may be contaminated 
from the normal use of such highly active 
therapeutic agents' (Aherne et al., 1985). 
Aherne and colleagues could not have known 
about the Thames Water studies as they were 
confidential. Moreover, the significance of their 
work and the earlier studies by Tabak and 
colleagues was not recognised, because the human 
health agencies responsible for international drug 
regulation at the time usually had limited expertise 
in environmental issues; consideration of these 
was not formally required. The situation is today 
very different, with environmental exposure now 
recognised as a key consideration (for example in 
European Medicines Agency guidelines (EMA, 
2006) (5). Moreover, until the 1990s, any concerted 
chemical analytical efforts to look for drugs in 
the environment achieved limited success. This is 
because the requisite chemical analysis tools (with 
sufficiently high separatory powers to identify 
the drugs amid a plethora of other natural and 
anthropogenic substances in the environment, and 
sufficiently low detection limits (i.e. nanograms 
per litre or parts per trillion)) were not commonly 
available.
Now there is considerable concern about the 
increasing amounts of pharmaceuticals that are 
being consumed and found in the environment 
(Kümmerer, 2004 and 2007; Apoteket AB et al., 2006 
and 2009; EEA, 2010; German Advisory Council on 
the Environment 2007; Mistrapharma, 2011). With 
an ageing population the UK Office of National 
Statistics predicts that the country's medicine usage 
will more than double by 2050 (Nature, 2011).
13.2.2 More evidence of an environmental problem 
In the mid‑1980s, fisheries scientists working for 
the UK Ministry of Agriculture Fisheries and 
Food, or MAFF (Dr Colin Purdom, Dr Vic Bye 
and Dr Alex Scott) were asked to comment on the 
evidence collected to date. Quite independently, 
one of their colleagues, Dr John Sumpter, had 
found high levels of a female‑specific yolk protein 
(vitellogenin or VTG) in the blood of male fish 
kept at an experimental fish farm rented by MAFF. 
VTG is under strict oestrogen control and as males 
have extremely low (often undetectable) levels of 
oestrogen in their blood, they can only produce 
VTG if they are exposed to an oestrogen (Sumpter 
and Jobling, 1995). The scientists wondered 
whether the fish were being supplied with water 
contaminated with oestrogens originating from the 
treated sewage effluent entering the river upstream 
of the fish farm, and whether oestrogens in the 
water might also explain the discovery of feminised 
wild male fish in the River Lea. 
Field trials in the late 1980s, funded by the 
Department of the Environment (DoE), confirmed 
that VTG levels in male trout placed for just two 
weeks in the sewage treatment plant effluent from 
Rye Meads sewage treatment works (which entered 
the River Lea) underwent a 100 000 fold increase, 
reaching levels equivalent to those in mature 
females. These results provided the impetus for a 
nationwide survey of effluents (conducted between 
1987 and 1990) by Brunel University (John Sumpter 
and Charles Tyler) and MAFF (Colin Purdom, 
Vic Bye, Sandy Scott and Peter Hardiman), with 
funding from the DoE. The results of this survey 
proved beyond doubt that oestrogenic effluents 
entering rivers were widespread throughout 
England and Wales (Purdom et al., 1994). 
By the late 1980s, therefore, there was already 
evidence that wastewater from sewage treatment 
plants was having harmful effects on aquatic 
wildlife, and that at least one possible culprit was 
EE2. This information was not widely circulated 
beyond government and industrial organisations. 
Indeed, the results were not published until 1994 
(Purdom et al., 1994), because of the contractual 
agreement between the DoE, MAFF and Brunel 
University. There was little action: policymakers 
of that era perhaps preferred to wait until the level 
of proof linking cause with effect was beyond 
reasonable doubt, reflecting a wider resistance at 
the time to precautionary action in the absence of 
higher levels of proof. 
Subsequent research has proven EE2's presence in 
effluents and natural waters, and established that it 
(5) More recent guidance from the European Medicines Agency states that if the estimated environmental concentration (i.e. predicted 
surface water concentration) of a medical product is below 0.01ppb and 'no other environmental concerns are apparent' then no 
further actions are needed in terms of environmental risk assessment, i.e. no action needed by a pharmaceutical company.
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is highly likely that it is contributing significantly 
to the damaging effects seen in wild fish (Caldwell 
et al., 2009). Moreover, studies carried out in 
Canada have confirmed large effects associated 
with very low concentrations in a multi‑year study 
in which fish living in a large experimental lake 
were exposed to introduced EE2 (Kidd et al. (2007): 
6.1 ng/L (+/– 2.8) during the first year, 5.0 ng/L 
(+/– 1.8) during the second year and 4.8 ng/L 
(+/– 1.0) during the third year of. This low level 
introduction of oestrogen provoked a large surge 
in fish plasma VTG levels, followed by complete 
collapse of the fish population. The fundamental 
conclusion, that EE2 and other hormones in 
wastewater, both natural and synthetic, are 
harming aquatic wildlife, particularly downstream 
of wastewater plants with low dilution, has not 
changed since the late 1980s. Only the level of 
uncertainty has reduced. 
13.2.3 Widespread endocrine disruption in wild 
fish and growing evidence of problems in 
other wildlife
The discovery in the 1980s that oestrogenic 
effluents were widespread led logically to more 
caged fish trials that illustrated the extent of the 
oestrogenic pollution at greater distances from the 
sewage treatment works (Harries et al., 1996 and 
1997). Extensive field trials in the United Kingdom 
between 1995 and 2000 also showed unequivocally 
that intersex in wild roach was widespread and 
especially prevalent up to 10 km downstream of 
medium‑ to large‑sized sewage treatment works 
(serving populations of 50 000 to 675 000) and 
where dilution of their effluents in receiving river 
waters was less than 10‑fold (Jobling et al., 1998). 
In addition, studies on estuarine species of fish 
illustrated clearly that the effects of oestrogenic 
contaminants extended beyond the rivers into 
estuaries (Lye et al., 1997 and 1998; Allen et al., 
1999) Feminisation and sub‑fertility were also 
reported in additional wildlife species, especially 
those living in or around the aquatic environment 
(reviewed in Lyons, 2008). Specifically: 
•	 amphibians	were	found	to	have	abnormal	
production of VTG by males and ovotestes/
intersex features; 
•	 reptiles	were	found	to	have	abnormal	production	
of VTG by males: sex hormone disruption; 
ovotestes; smaller phallus in alligators and shorter 
estimated penis length in turtles; decreased 
hatching; and decreased post hatch survival; 
•	 birds	were	found	to	have	abnormal	VTG	
production in males; deformities of the 
reproductive tract; embryonic mortality; reduced 
reproductive success including egg‑shell thinning 
and poor parenting behaviour;
•	 otters	and	mink	were	found	to	have	reduced	
penile bone length; smaller testes; and impaired 
reproduction;
•	 seals	and	sea	lions	were	found	to	have	impaired	
reproduction (including implantation failure, 
sterility, abortion, premature pupping); 
•	 cetaceans	were	found	to	have	reduced	
testosterone levels; impaired reproduction; and 
hermaphrodite organs;
•	 polar	bears	were	found	to	have	intersex	features	
and deformed genitals; reduced testes and 
baculum length; low testosterone levels in adult 
males; and reduced cub survival. 
In none of these cases was a link with exposure to EE2 
investigated and/or proven.
13.2.4 Wildlife as sentinels for human reproductive 
health 
Beyond the aquatic environment, the feminising 
syndromes found in wildlife appeared to mirror 
reports of male infertility, genital abnormalities 
and testicular cancer observed in the human male 
population, collectively termed Testicular Dysgenesis 
Syndrome (TDS; see Box 13.1). If testicular dysgenesis 
syndrome was occurring in humans due to 
environmental pollutants, then genital disruption 
should have been found in wildlife exposed to 
those pollutants. This did indeed seem to be the 
case. The question arose whether the effects seen 
in wildlife and in humans shared a common cause: 
environmental oestrogens including EE2. There had 
already been evidence of human health impacts 
associated with another synthetic oestrogen created in 
the same year as EE2: diethylstilbestrol (DES). From 
the 1940s to the early 1970s, pregnant women in the 
US (and beyond) were commonly prescribed DES in 
the mistaken belief that it could prevent miscarriage. 
Some of the sons of these DES mothers developed 
low sperm counts, undescended testicles and 
deformations of the penis (Ibaretta and Swan, 2001).
The steepest declines in male reproductive health 
appear to have taken place in most countries between 
the 1960s and the 1980s, coinciding not only with 
the introduction and take up of the contraceptive 
Emerging lessons from ecosystems | Ethinyl oestradiol in the aquatic environment
318 Late lessons from early warnings: science, precaution, innovation
 
Box 13�1 Human health concerns
The first indications that something might be wrong with human sperm came in 1974, when Kinloch Nelson 
and Bunge produced a small study of the semen quality of men who were about to undergo vasectomies. 
They found that only 7 % had sperm concentrations above 100 million (Kinloch Nelson and Bunge, 1974), 
which is well below the 65 % reported earlier by pioneering andrologist, John Macleod (MacLeod and Heim, 
1945). 
Kinloch Nelson and Bunge speculated that 'an environmental factor to which the entire population has been 
exposed' might be causing the low sperm counts. These studies were discredited by John MacLeod himself 
in 1979. While acknowledging a decline in sperm counts in fertile males since the 1930s, MacLeod and 
Wang (1979) rejected the notion of a larger, overall decline, citing analytical errors in the Nelson and Bunge 
study and suggesting a concentration of 20 million per ml should be the lower limit for the normal sperm 
count.	This	limit	was	adopted	in	the	WHO	guidelines	for	semen	analysis	in	1980	(WHO,	1980).	
Nothing more was reported until 1992, when Danish clinician Niels Skakkebaek and Elizabeth Carlsen 
published their ground-breaking paper on studies of sperm counts around the world. In 61 studies going 
back as far as 1938, they found a decline in average sperm density from 113 million per millilitre in 1940 
to 66 million in 1990 (Carlsen et al., 1992). These findings made some scientists wonder whether the 
human species was approaching a fertility crisis. Debate on this issue was intense and opinion was divided 
regarding the validity of the apparent fall in global sperm counts (e.g. Swan et al., 1997; Paulsen et al., 
1996; Fisch et al., 1996). 
The approach taken in Europe (led by Skakkebaek) followed the reasoning that 'if sperm counts have fallen 
then the average should be lower in men born most recently than they were in the past'. More recent 
investigations in seven European countries involving more than 4 000 young men have shown that in 
most of the countries investigated 20 % or more of young men have a subnormal sperm count (less than 
20 mn per ml) and the average sperm count is 45–65 million (Jorgensen et al., 2006). This is consistent 
with sperm counts having fallen, as suggested by the meta-analysis studies. More importantly, it shows that 
male subfertility is likely to be a common issue for current and future generations, with widespread societal 
and economic consequences.
The importance of declining semen quality lies partly in its possible link with other problems of male 
reproductive organs, especially the rise in the incidence of testicular cancer (Adami et al., 1994; 
Wanderas et al., 1995; Bergstrom et al., 1996; Moller, 2001; McGlynn et al., 2003; Richiardi, 2004) 
and in congenital malformations of the male reproductive system such as cryptorchidism (undescended 
testis)	and	hypospadias	(penis	malformation)	(Hohlbein,	1959;	Sweet	et	al.,	1974;	WHO,	1991;	Matlai	
and Beral, 1985; Paulozzi et al., 1997; Lund et al., 2009). These diseases often occur together (Prener, 
1992; Berthelsen, 1984; Petersen et al., 1999; Schnack et al., 2009) and may have the same underlying 
pathology — testicular dysgenesis syndrome (TDS) (Sharpe and Skakkebaek, 1993; Skakkebaek, 1998) 
with a common origin in fetal life (see Figure 13.2). 
Source: Sharpe and Skakkebaek, 1993.
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Figure 13�2 Testicular dysgenesis syndrome
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Box 13�1 Human health concerns (cont�)
Unlike in the case of intersex in fish, there has never been one widely accepted theory regarding the cause 
of the decline in male reproductive health. Instead, a bewildering array of hypothetical culprits have been 
posited, including not only the residues of birth control pills in drinking water or inadvertent pill taking during 
pregnancy, but also a range of anti-androgenic industrial chemicals (male hormone lowering or blocking) 
and non-chemical stressors that have been shown in laboratory studies to induce TDS when exposure takes 
place during early pregnancy (Sharpe, 2009). The research in this field has been challenged by the lack of 
human exposure information and the absence of results of past testing of industrial chemicals for endocrine 
disruption and other adverse effects that may affect the development of the male reproductive system. Even 
if animal testing is performed, the results cannot directly be translated to humans because, for example, a 
chemical may reduce sperm counts by 80–90 % in rats before male fertility is affected. 
The net result is that no systematic effort has been made to prevent infertility, despite the substantial 
potential	societal	consequences	associated	with	its	widespread	occurrence.	Indeed,	the	official	WHO	
response to male infertility has been to redefine the ill people as 'normal' by changing the lower reference 
value for a 'normal' sperm concentration first from 60 mn/ml in 1940s to 20 mn/ml in 1980 and then to the 
current	15	mn/ml	(WHO,	2010),	making	it	of	little	use	in	helping	society	recognise	that	there	is	a	problem	
(Skakkebaek, 2010). 
pill but also with the entry of many other synthetic 
chemicals into the environment, the Clean Water 
Act in 1972 and subsequent upgrading of sewage 
treatment plants to secondary treatment. Thus, 
endocrine disruption in the developing child could 
have occurred through the inadvertent consumption 
of pills in the first trimester of pregnancy (Smithells, 
1981, although refuted by Joffe, 2002). Alternatively, 
or additionally, it could have resulted from drinking 
water containing residues of contraceptive pill 
hormones and a whole plethora of industrial 
chemicals. Or it could have resulted from inadvertent 
exposure to these chemicals via application to the 
skin (cosmetics), inhalation or diet. A more recent 
report highlights a relationship between modern 
contraceptive pill use and prostate cancer (Margel 
and Fleshner, 2011), another hormone‑dependent 
male reproductive disease.
In the case of the contraceptive pill, one might 
expect the exposure to have been higher in the 1960s, 
1970s and 1980s than in later years as the first pill 
formulations contained up to 100 μg of oestrogen, at 
least five times higher than current formulations. If 
exposure to the contraceptive pill was a significant 
risk factor in causing TDS, the effects should show up 
in statistics on male reproductive health. 
Examination of historical contraceptive pill usage in 
various countries does indeed suggest higher rates of 
use (allowing a 30–35 year time lag between exposure 
of the developing child and the later appearance of 
testicular cancer) in some countries where rates of 
testicular cancer and hypospadias are higher, such as 
Denmark, Germany, Hungary, the United Kingdom 
and USA, than in countries where rates are lower, 
such as Bulgaria, Finland, Italy, Poland, Portugal, 
Romania and Spain and Japan (Leridon et al., 2006). 
These associations may well be coincidental, however, 
as the available evidence in support of the oestrogen 
theory is not entirely convincing (Raman‑Wilms 
et al., 1995; Toppari et al., 1996; Martin et al., 2008). 
Indeed, recent animal experimental studies suggest 
that industrial chemicals that block the action of male 
hormones (anti‑androgens) are more likely culprits 
of declines in male reproductive health and could 
even act in combination with oestrogens to induce 
a proportion of the cases of TDS seen in humans. 
So far, however, 'there is no human or experimental 
animal data to support this' (Sharpe, 2009). The lack 
of cause‑effect, especially in human epidemiological 
studies, could easily be wrongly interpreted as ruling 
out involvement of endocrine disruptors in TDS. 
Several factors complicate analysis, including the 
long latency between exposure and effect and the 
possibility that the effects may be caused by multiple 
chemicals in combination, while exposure to each 
chemical individually may not be insufficient to cause 
damage. This is also why Bradford Hill's criteria, 
when invoked in the 2002 WHO report on endocrine 
disruption (WHO, 2002), rejected the hypothesis 
of an impact on male reproductive function. These 
criteria are not suited for determining causation by 
environmental toxicants because such exposures are 
simply too complex. Perhaps we should abandon the 
unrealistic hope of achieving more certainty prior to 
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policymaking about human male reproductive health 
and use wildlife as sentinels instead? 
The case for endocrine disrupting chemicals causing 
male sterility in humans and wildlife, showing 
wildlife were sentinels for human health, was 
beautifully presented in the British Broadcasting 
Company's award‑winning Horizon documentary 
'Assault on the male', written and produced by 
Deborah Cadbury and screened in 1993. The world 
began to sit up and take notice. Mounting concern 
in Europe was such that between 1998 and 2007 the 
European Commission invested over EUR 150 million 
into researching endocrine disruption. This research 
provided the basis for testing both existing chemicals 
and those planned for introduction to the market 
in the future for their endocrine disrupting effects. 
It also furthered understanding of the effects 
of mixtures of endocrine disrupting chemicals, 
identification of vulnerable life stages and impacts 
on male reproductive health. The new data showed 
that a wide range of chemicals could have endocrine 
disrupting effects, with a wide range of health 
impacts. 
13�3 The hunt for the culprit chemicals
Against the backdrop of growing global awareness 
of endocrine disruption, attention focused on the 
chemicals responsible for the feminised male fish 
observed in UK rivers. Laboratory studies showed 
clearly that male fish were extremely sensitive 
to the presence of EE2 in the water at low ng/L 
concentrations (Sheahan et al., 1994). Until the 
mid‑1990s, however, few were convinced that this 
or any other hormone was present in wastewater in 
sufficient amounts to cause the effects seen in fish.
Coincidentally, during that time information 
was emerging from the US that, in addition to 
pharmaceuticals, industrial chemicals in everyday 
use could mimic oestrogens. Although this was first 
shown by Charles Dodds in the 1930s (Dodds et al., 
1936), widespread awareness of this possibility was 
instigated by John McLachlan, one of the pioneers 
of research into environmental oestrogens and the 
organiser of the first meeting on the topic in 1979 
(McLachlan, 1980). 
It now seemed possible that effects seen in 
aquatic and other wildlife were actually more 
likely to be a result of exposure to cocktails of 
'endocrine‑disrupting' industrial chemicals, 
(Clement and Colborn, 1992) than to the 
contraceptive pill hormone. In 1988 Theo Colborn, 
in her research on the environmental condition 
of the North American Great Lakes, showed 
that persistent, man‑made chemicals were being 
transferred from top predator females to their 
offspring, undermining the construction and 
programming of their youngsters' organs before 
they were born. In 1991, Theo convened a meeting 
('The Wingspread Meeting') of 21 international 
scientists from 15 different disciplines to share 
relevant research on the topic and it was during 
this meeting that the term 'endocrine disruption' 
was coined. 
It was also in 1991 that Dr Ana Soto published a 
paper about the oestrogenic effects of nonylphenol, 
a chemical compound used in manufacturing a 
large group of industrial detergents (Soto et al., 
1991). Some detective work by Susan Jobling (then 
a student of John Sumpter) at Brunel University 
revealed that the environmental chemist Walter 
Giger had identified these chemicals in sewage 
treatment works effluents, sewage sludge and river 
water (Giger et al., 1984) at concentrations that 
Jobling later confirmed were oestrogenic to fish 
exposed to the chemicals in the laboratory (Jobling 
and Sumpter, 1993; Jobling et al., 1996). 
An earlier report of the oestrogenic activity of 
4‑nonylphenol, was published in 1936 by Charles 
Dodds when he was trying to synthesise one of the 
first synthetic oestrogens, diethylstilbesterol (6). 
The detergent industry may have been unaware of 
this literature when it embarked on the largescale 
manufacture and sale of nonylphenol ethoxylates 
as detergents in the 1940s, leading to the 
contamination of many rivers and estuaries with 
these oestrogenic chemicals. 
While the causal links between exposure to 
industrial chemicals and endocrine disruption 
in most wildlife species were still unclear in the 
1990s, further research in the United Kingdom 
and other European countries showed that 
nonylphenolic chemicals were causing at least part 
of the problem in wild fish in some, but not all, 
areas (Sheahan et al., 2002a and 2002b). However, 
more sophisticated studies employing chemical 
fractionation and screening of effluents using an 
in vitro oestrogenicity screen showed that naturally 
occurring and synthetic steroid oestrogens (EE2, E2 
(6) Interestingly, Dodds identified another controversial compound at the same time — the environmental endocrine disruptor 
bisphenol-A (Dodds, 1938). See also Chapter 10 on BPA.
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and E1) were in fact the most potent oestrogenically 
active substances present in domestic effluents 
(Desbrow et al., 1998; Routledge et al., 1998; 
Snyder et al., 2001), responsible for much of the 
oestrogenic activity found in wastewaters and 
rivers throughout most of the world. Of these, EE2 
was by far the most potent: the pill was once again 
under the spotlight. 
13�4 Government and industry action in 
the 1990s
Enormous efforts were made in the 1990s to assess 
and manage the risks of alkyphenols, not only 
because of their endocrine disrupting effects but 
also their wider toxicity to aquatic life:
Following recommendations of the UK Chemicals 
Stakeholder Forum, the UK government negotiated 
a voluntary agreement with the suppliers of 
nonylphenols, octylphenols, and their respective 
ethoxylates. Suppliers thereby agreed not to 
promote octylphenol (another endocrine disruptor 
also found in sewage effluent) as a substitute 
for nonylphenols, not to manufacture or import 
new formulations or products containing those 
substances, and to reformulate existing products 
to remove those substances as a matter of urgency. 
This was a constructive application of the 
precautionary principle (Lokke, 2006), which has 
not been extended to EE2. 
Similarly, in mainland Europe, the European Union 
undertook a risk assessment of nonylphenols and, 
as a result, restrictions on using nonylphenol have 
been imposed across Europe. 
At the same time, continued uncertainty about 
exposure to chemical pollutants in the environment 
and their effects on the human population 
(particularly regarding reproductive health) 
were highlighted during discussions at a major 
European workshop at Weybridge, the United 
Kingdom (7), on endocrine disrupting chemicals 
held in December 1996 and jointly sponsored by the 
European Commission, the European Environment 
Agency, the European Centre for Environment and 
Health and the WHO (EU, 1996). An EU strategy 
on endocrine disruptors was launched in 1999 to 
begin to address the problem (EU, 1999) but still no 
action was taken on EE2.
13�5 The last decade of research 
Since the mid‑1990s, oestrogenic sewage‑treatment 
works effluents have been identified more widely 
across Europe, and globally, e.g. in Denmark 
(Bjerregaard et al., 2006), Germany (Hecker et al., 
2002), the Netherlands (Vethaak et al., 2005), 
Portugal (Diniz et al., 2005), Sweden (Larsson et al., 
1999), Switzerland (Vermeirssen et al., 2005), China 
(Ma et al., 2005), Japan (Higashitani et al., 2003) 
and the United States (Folmar et al., 1996). More 
extensive evidence has also emerged from around 
the world showing widespread endocrine disruption 
in fish in rivers (Hinck et al., 2009; Bjerregaard et al., 
2006; Blazer et al., 2007; De Metrio et al., 2003; Hinck 
et al., 2009; Penaz et al., 2005; Vajda et al., 2008), 
estuaries (Allen et al., 1999) and oceans (Cho et al., 
2003; Ohkubo et al., 2003; Fossi et al., 2004; Kirby 
et al., 2004; Scott et al., 2006 and 2007). 
In general, the situation in other countries appears 
to match that found in the United Kingdom. The 
incidence and severity of endocrine disruption 
appears to relate largely to the size of the sewage 
works (treatment type is also important), most 
importantly, and the dilution of its effluent in 
the receiving water. This leads to generally lesser 
effects in fish inhabiting large rivers with high 
dilution factors (a common scenario in the US and 
parts of Europe, for example) compared with those 
in smaller rivers with little dilution (a common 
scenario in the United Kingdom and other parts 
of Europe). In Japan, where contraceptive pill 
hormone use is probably the lowest anywhere in the 
developed world and where endocrine disruption 
in fish is reported to be quite rare (Tanaka et al., 
2001; Higashitani et el., 2003), the greater mean river 
flow, and hence available dilution per capita (five 
times more than in the United Kingdom), suggests 
that combined steroid estrogen potency will be 
less across its rivers than in the United Kingdom. 
Even if the Japanese population were to take up the 
contraceptive pill to the extent of use in England 
then widespread endocrine disruption in fish would 
still not be predicted because of the large amount of 
available dilution (Johnson et al., 2012). 
A growing body of evidence also shows that the 
harm caused by exposure to endocrine disrupting 
chemicals early in development is, in many cases, 
irreversible. In fish, as in humans and rodents, 
feminisation of the male reproductive tract occurs 
early in development and produces a fish with 
(7)  In 2006 the 10th anniversary of Weybridge was marked with a conference organised by the Academy of Finland, the European 
Commission (DG Research), and the EEA. The EEA has updated and published the papers from that meeting (EEA, 2012).
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both an oviduct and a sperm duct. Depuration 
in clean water does not correct this condition, 
indicating that feminised ducts seen in wild roach 
are likely to be a permanent feature (Rodgers‑Gray, 
2001). Considerable evidence also shows that both 
the prevalence and the severity of feminisation 
in wild roach increases with age (Jobling et al., 
2006), in extreme cases resulting in a 100 % female 
population after three years of continuous exposure 
to treated sewage effluents or EE2 (Lange et al., 
2009). 
Population‑relevant effects of EE2 have also been 
documented, including a complete fish life cycle 
test carried out by the original manufacturers of 
EE2, Schering (Lange et al., 2001), which showed 
inhibition of breeding at concentrations exceeding 
the environmentally relevant concentration of 
2 ng/L and full sex reversal of males producing 
an all female population at 4 ng/L. This effect was 
corroborated by Kidd et al., (2007), who (as we 
have already noted) dosed an entire lake with EE2, 
causing a population collapse at concentrations of 
approximately 5–6 ng/L.
Improvements in analytical power, lower analytical 
instrument detection limits and innovative 
modelling approaches have led to the discovery of 
other steroid oestrogens in the environment, such 
as equine oestrogens used in hormone replacement 
therapies (Tyler et al., 2009). There are now also 
more accurate measurements (Williams et al., 
2003; Kanda and Churchley, 2008) and credible 
modelled estimates (Hannah et al., 2009) of steroid 
oestrogen concentrations present in sewage effluents 
and in rivers . This has caused a mixture of doubt 
and amazement at the possibility that EE2 could 
be causing endocrine disruption at the very low 
concentrations at which it is present. 
The last decade has also brought the realisation 
that risk assessments for mixtures of hormonally 
active chemicals are not adequately protective if 
based on data for individual substances. Mixtures of 
synthetic and natural oestrogens (EE2, E2, E1) each 
at or below their individual 'no effect' concentration 
were shown to be particularly potent when present 
in combination (Silva et al., 2002; Thorpe et al., 2003; 
Brian et al., 2005 and 2007) or with other industrial 
chemicals with anti‑androgenic (male‑hormone 
blocking) activity. These findings confirmed 
concerns originally mooted by Rachel Carson in 
1962 in her book, Silent Spring.
More recent reports show an almost concurrent 
incidence of anti‑androgenic chemicals and 
oestrogens in treated wastewater throughout the 
United Kingdom. Statistical modelling of exposure 
and effect data suggest that these chemicals (although 
not yet identified) could play a pivotal role in causing 
feminising effects in male fish in UK rivers. Until now 
it was thought that such effects were caused only by 
oestrogens found in contraceptive pills and some 
industrial chemicals (Jobling et al., 2009).
There may be a further twist in the story. Synthetic 
progesterones (which complement synthetic 
oestrogen in the contraceptive pill) have been 
identified in natural waters (Standley et al., 2008; 
Kuster et al., 2008) and reported to cause effects in 
fish when present at ng/L concentrations (Paulos 
et al., 2010; DeQuattro et al., 2012). Ironically, despite 
the history of their combined use, oestrogens 
and progesterones have yet to be tested in fish 'in 
combination', despite the fact that human females 
have been carrying out this 'test' for 50 years. 
13�6 From risk assessment to risk 
management 
In 2004, some 25 years after initial observations 
of intersex in fish, the UK government accepted 
the weight of evidence that EE2, E2 and E1 in 
combination posed a significant risk to aquatic 
life through their endocrine disrupting effects 
(Gross‑Sorokin et al., 2006). The long journey to 
this point was passionately championed by Geoff 
Brighty, Science Manager at the Environment Agency 
of England and Wales. His team, in collaboration 
with others, built and defended the evidence‑based 
case against steroid oestrogens and other endocrine 
disrupting chemicals in UK rivers.
As Brighty remarked in 2004, 'We now have enough 
data to act as a policy trigger for taking action' 
(ScienceBlog, 2004).
End‑of‑pipe treatment of effluent by water companies 
was chosen as the risk management approach, 
in comparison to alternative approaches (such as 
pharmaceutical industry action to develop substitutes 
for the active ingredient (EE2) in the pill). This may 
have partly reflected awareness of the public health 
benefits of the oral contraceptive, the fact that both 
naturally‑excreted and synthetic oestrogens posed 
risks via their endocrine disrupting effects (i.e. that 
both would need to be removed) and that other 
priority hazardous chemicals would also be reduced 
with the end‑of‑pipe treatment approach.
This would place the responsibility for risk 
management on the water industry and (ultimately) 
the cost of treatment of the tax paying public. In 
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2007 the Environment Agency began to develop a 
(draft) technical environmental quality standard 
(EQS) — a target concentration which could be 
used for regulatory compliance for EE2‑ based on a 
predicted no effect concentration of 0.1ng/L (Young 
et al., 2004, Figure 13.3). The Environment Agency 
also identified the EU Water Framework Directive 
(WFD) as an appropriate legislative mechanism 
within which the EQS could be enforced. Options 
for control under the WFD might be to propose EE2 
either as a nationally important 'specific pollutant, 
or an EU‑wide 'priority substance' requiring control 
across Europe. The WFD is the most important 
EU legislation for managing water resources 
and had already been used to regulate other 
endocrine disrupting chemicals such as TBT and 
nonylphenol. Since additional endocrine disrupting 
chemicals were likely to be proposed as 'specific 
pollutants' or 'priority substances' in order to 
decrease their overall environmental burden, this 
was a reasonable option for the steroid oestrogens. 
At this point, no other country in the world had 
Environmental Quality Standards for any of these 
substances (8).
Before introducing risk management of this type 
there is an important step known as risk evaluation, 
which quantifies the wider consequences and costs 
to society of the proposed management approach 
and balances them against the benefits. The various 
options on how to proceed are then evaluated 
and a decision made. For example, a regulatory 
impact assessment may be undertaken to evaluate 
the implications of bringing in regulation and 
implementing an EQS. 
In the case of EE2 and the other two steroid 
oestrogens it was necessary to understand the 
efficiency of various treatment approaches in 
removing these substances from sewage treatment 
plant final effluents. The approaches included both 
existing and new (advanced) treatment methods: 
these would need to be quantified in terms of both 
financial and carbon costs. 
In 2004 the UK water industry, in collaboration 
with the Environment Agency and the 
UK government, and under the watchful eye of 
the independent auditor Ofwat, commenced a 
comprehensive and lengthy work programme 
to address this goal. The so‑called 'National 
Demonstration Programme' (Gross‑Sorokin, 2006) 
was budgeted at GBP 25–40 million and was 
not welcomed by the UK water industry, which 
financed most of the costs. All ten water companies 
in England and Wales were involved. 
In the first phase of the programme fourteen sewage 
treatment plants were used to evaluate the efficiency 
of oestrogen removal through 'conventional' 
treatment technologies. These consisted of primary 
or chemically aided primary sedimentation with 
secondary treatment by nitrifying, non‑nitrifying 
activated sludge (ASP) or biological filtration and 
in some cases tertiary sand or biologically aerated 
filtration. In the second phase, two so‑called 
'full‑scale' plants were used to evaluate the most 
promising new technology as an additional 
Note:  In rivers and streams coloured red the suggested 
Predicted No Effect Concentration (PNEC) for EE2 
of 0.1 ng/L is exceeded. In rivers coloured green 
the combined concentrations of steroid oestrogens 
(in EE2 equivalents) are less than the suggested PNEC.
Figure 13�3 UK rivers and streams exceeding 
the Predicted No Effect 
Concentration (PNEC) for EE2
(8) In the US, for example, the FDA regulates pharmaceutical manufacture and the EPA regulates discharge under the Clean Water Act. 
However, these limitations may not be strict enough to protect the environment because they are technology-based and do not rely on 
environmental data. As explained later, there is no treatment technique currently available that comprehensively deals with EE2.
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advanced tertiary effluent treatment: granular 
activated carbon (GAC).
The first phase of the Demonstration Programme 
was completed in mid‑2008 (UKWIR, 2009). Results 
showed that while existing treatment approaches 
were effective for removal of oestrone and oestradiol, 
particularly using nitrifying activated sludge 
treatment, EE2 was far harder to remove. The most 
efficient treatment, nitrifying ASP, removed some 
54 %, with tertiary treatments accounting for a further 
reduction of 0–38 % of that remaining, depending on 
the form of tertiary treatment.
These results are completely in line with the 
consensus seen in current international scientific 
literature, as comprehensively reviewed by Racz and 
Goel (2010). Wastewater treatment plants with long 
retention times (greater than 10 days), especially 
those performing nitrification, seem to be generally 
more effective at removing oestrogens because they 
allow the enrichment of slow‑growing bacteria, 
such as nitrifying bacteria, and the establishment 
of a more diverse ecological community including 
species capable of degrading EE2. For this reason, 
expensive membrane bioreactors with microfiltration 
and ultrafiltration as well as long retention times 
have been shown to effectively degrade and reduce 
the concentrations of oestrogens in effluents, 
including EE2. 
In general, however, EE2 is not nearly as easily 
biologically removed as the other oestrogens. The 
ethinyl group of EE2 is thought to hinder EE2 
sorption and metabolism. Furthermore, EE2 often 
exists in the aquatic environment at concentrations 
below those at which a substrate can support bacterial 
growth. Biodegradation studies at EE2 concentrations 
greater than those found in natural environments 
(mainly conducted at such concentrations due 
to limitations in analytical chemistry techniques) 
may therefore lead to erroneous conclusions about 
the occurrence, rates and products of microbial 
transformation of EE2 and the other steroid 
oestrogens. 
As a consequence of removal inefficiencies, the 
proposed EE2 Predicted No Effect Concentration 
(PNEC) of 0.1 ng/L is exceeded in many UK final 
effluents entering the aquatic environment, 
irrespective of conventional treatment type (see 
Figure 13.3). The results of the second phase of the 
UK Demonstration Programme were reported in 
May 2010 (NDP, 2010). They showed that additional 
treatment using a novel approach called granular 
activated carbon (GAC) can be effective at removing 
EE2, producing final effluents below the EE2 PNEC 
and with no significant induction in fish VTG or 
intersex (Filby et al., 2010; Baynes et al., 2012). GAC 
could therefore offer the most promising route for 
preventing EE2's entry into the aquatic environment 
at harmful levels (noting that in one study 
reproduction in fish was slightly, but significantly 
impacted by effluent subjected to GAC treatment). 
The Demonstration Programme showed, however, 
that GAC suffers from a fundamental problem: it is 
expensive to implement.
For a small town with a 50 000 population 
equivalent (PE) sewage treatment plant, the capital 
costs alone of setting up additional GAC were 
calculated as being over EUR 3 million. That rose to 
over EUR 8 million for a 250 000 PE works serving a 
large town such as Swindon, which was one of the 
sites chosen in the United Kingdom for assessing 
the technology. Operating costs per annum were 
calculated as being EUR 800 000 for a 250 000 PE 
sewage treatment plant, but this would depend 
on the life of the granular activated carbon. Costs 
were calculated to approximately 14 kg of CO2 per 
person per year. Provisional estimates by the UK 
government showed that, in total for England and 
Wales, this would translate into costs of between 
EUR 32 and 37 billion for the approximately 
1 360 sewage treatment works that would require 
additional treatment (Owen and Jobling, 2012). 
Again, these findings are in line with the findings 
of Racz and Goel (2010), who concluded that 'Much 
attention has also been placed on studying methods 
of removing oestrogens prior to discharging 
effluent or disposing waste sludge. While advanced 
treatment systems such as chemical removal, 
activated carbon, chlorination, ozonation, ultraviolet 
irradiation, membrane separation, and other novel 
approaches may be effective, their current capital 
and operation costs may make them not viable 
options.' 
Faced with this information, those tasked with 
implemention of an EQS for EE2 (for example as 
a 'priority substance' under the Water Framework 
Directive, see below) increasingly began to worry 
about two important considerations: technical 
feasibility and disproportionate cost. It confirmed 
what they had suspected for many years: EE2 was 
potent and hard to get rid of. 
Evaluation of risk management costs, which 
have to be calculated at a national scale given 
the widespread nature of endocrine disruption 
(Figure 13.4), is however only one half of the cost 
benefit equation. They must be balanced against the 
(often intangible) benefits of risk management to 
key stakeholders, such as the angling community, 
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and the public, who will ultimately have to pay 
for it. This has been a highly contested and often 
acrimonious area of debate, with highly charged 
discussions about what constitutes harm at the 
level of individual fish and what it means for (more 
ecologically important) fish populations. Adding 
to this debate is the fact that the costs associated 
with removing EE2 and E2 should not be seen in 
isolation: treatment such as GAC would also quite 
possibly serve to reduce/remove other substances 
posing risks to the environment and requiring 
control. Why should such removal costs not be 
considered for all such chemicals as a whole: is it 
scientifically incorrect to blame just EE2 for the 
costs? 
Another consideration is how such costs might 
scale at an EU‑wide level, where EU‑wide 
regulation might occur. One European Commission 
estimate for this is EUR 11–18 per person per 
annum (EC, 2012). EUREAU (European Federation 
of National Associations of Water and Wastewater 
Services) however estimates that these costs 
are much higher; 25–50 % of the current annual 
sewerage charges per year (EUREAU initial position 
paper on amending Directives 2000/60/EC and 
2008/105/EC as regards priority substances in the 
field of water policy). There is clearly considerable 
uncertainty here.
The costs at an individual country level are likely 
to vary on a country by country basis, for example 
varying with the population density, status of 
wastewater treatment and size of rivers. In some 
cases individual country costs may be substantially 
lower than those estimated for the United Kingdom 
(e.g. see EU project Neptune and the Swiss project 
Micropoll; Eawag, 2009). Many European countries 
have lower population densities and much greater 
dilution of effluents in their receiving rivers than 
seen in the United Kingdom. Consequently, the total 
national costs of complying with any regulation 
concerning EE2 could be considerably lower in these 
countries than in the United Kingdom. In addition, 
the quality of treatment plants in mainland Western 
Europe is in general higher than in the United 
Kingdom. In Germany, for example, most sewage 
treatment plants have three stages and some even 
have a fourth stage, whilst in the United Kingdom, 
two stages are most commonly encountered. As 
we have already noted, the addition of a third 
stage, whether it be GAC, mild ozonation or simple 
sand filtration could cause dramatic reductions 
in estrogen concentrations and their biological 
effects on fish. As recently demonstrated by Baynes 
et al. (2012) using biological effects rather than 
chemical concentrations as measures of effective 
risk reduction, sand filtration following activated 
sludge treatment was almost as effective as GAC at 
preventing the feminisation of male fish albeit it was 
two thirds cheaper. 
For a number of years the decision of whether or not 
to regulate EE2 appeared to stall in the still waters of 
cost‑benefit analysis, with little chance of resolution 
and little movement forward. Then, in January 2012, 
the European Commission proposed a revised list 
of 'priority substances' for the Water Framework 
Directive (EC 2012). This included the oestrogens 
17β-oestradiol	and	17α-ethinyloestradiol.	The	
proposed regulatory EQS for EE2 was 0.035 ng/L 
for inland surface waters (e.g. rivers and lakes): 
this is the annually‑averaged limit in these water 
bodies. If this proposed EQS is adopted (a first 
vote on which occurs in the European Parliament's 
Environment, Public Health and Food Safety 
Committee in November 2012), it could be taken 
into account in the 2015 updated River Basin 
Management Plans and associated 'Programmes of 
Measures' across Europe, with enforcement required 
by 2021. But even now, nearly 75 years after its 
Figure 13�4 Extent of sexual disruption in 
roach in English rivers
Note:  Intersex was present at 44 (86 %) of 51 sites 
surveyed, with an aggregate incidence of intersex of 
23 % of sampled males. Coloured symbols indicate 
incidence of intersex at the different river sites 
surveyed. 
Source: Taylor et al., 2005.
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initial manufacture in 1938, and decades of research 
concerning its environmental endocrine disrupting 
effects, this remains a proposal requiring agreement: 
the decision to regulate or not is yet to be made and 
may be stalled by recent representations to the EC 
from both the water and pharmaceutical industries 
(EUREAU, 2012).
Indeed in July 2012 an amendment to this proposal 
was tabled, stating 'It is appropriate not to specify 
the EQS for certain substances of pharmaceutical 
relevance that have been added to the list of priority 
substances' and that 'The Commission should 
propose the EQS for these substances in the next 
review of the list in 2016, and appropriate measures 
should be introduced…with the aim of meeting the 
EQS by 2027' (9).
13�7 Late lessons
Ethinyloestradiol, the active ingredient in the 
birth control pill, has allowed women to control 
their fertility reliably on a global scale. But it has 
come at a price to the environment. As mixtures, 
EE2 and other oestrogens, both synthetic and 
natural, have been shown to have serious impacts 
on wildlife — impacts that can be associated with 
early life exposure but manifest themselves later 
in adult life. Such impacts are often sub‑lethal but 
may be permanent and irreversible. They may also 
serve as sentinels for impacts on human health 
via environmental oestrogen or other endocrine 
disrupting chemical exposure. 
Since wildlife is exposed to a cocktail of endocrine 
disrupting chemicals, it is naive to conclude that 
EE2 alone is the culprit. It is, however, the most 
potently oestrogenic of the steroid oestrogens, 
occurring widely in effluents entering the 
environment, at concentrations that can frequently 
exceed the Predicted No Effect Concentration 
of 0.1 parts per trillion (UKWIR, 2009). There is 
reasonable certainty, based on sufficient scientific 
evidence, that EE2 plays a significant role in 
causing the reproductive health impacts observed 
in fish. The need for risk management has been 
accepted by both the Environment Agency of 
England and Wales (Gross‑Sorokin et al., 2006) and 
by the European Commission through its proposal 
for EE2 to become a priority substance requiring 
control (EC, 2012).
But this is a story that is far from over, and is one 
that continues to raise important questions that will 
apply not only to EE2 but to any other pollutants 
exerting damaging but often sub‑lethal effects at 
very low concentrations. For a decision to regulate 
EE2 has not been agreed. A critical question 
is whether we as a society are willing to pay a 
potentially very high premium to be precautionary 
and exclude EE2 from the environment. 
Alternatively, would we, as a society, prefer to live 
with the impacts of EE2 and other oestrogens on 
wildlife; are they acceptable risks? To what extent 
is society, which ultimately bears the benefits of 
flexible fertility but also the costs of cleaning up 
its unintended consequences on the environment, 
having a say on this decision?
This historical retrospective allows us to identify 
several important lessons, which are central 
not only to regulation of EE2 and other steroid 
oestrogens but also for many other low‑level 
chemical pollutants in the environment with 
sublethal effects, alone or in combination, now and 
in the future. 
13.7.1 Lesson 1: for low-level pollutants in 
the environment, is the price of being 
precautionary simply too high?
With regulation of EE2 now a serious proposal 
in Europe, the water industry, regulators and 
national governments are faced (as will be the case 
with many other low‑level pollutants) with risk 
management that will be a costly process if EE2 is 
to be removed from sewage treatment works final 
effluents to the vanishingly low levels that will be 
required for compliance. The target level proposed 
by the EC for EE2 as an annual EQS has been set at 
0.035 ng/L for inland surface waters (e.g. rivers and 
lakes). This is the regulatory concentration in the 
water body itself, not in the final effluent discharged 
from the sewage treatment works. However, as the 
UK Demonstration Programme has shown, reducing 
levels of EE2 in final effluents via end‑of‑pipe 
treatment to enable compliance with this EQS 
(e.g. for those water bodies with low dilution 
receiving large volumes of oestrogenic effluent) 
will be extremely difficult, The most promising 
technology, granular activated carbon, might achieve 
this, but it is expensive and may have a potentially 
large carbon footprint. Mild ozonation may also be 
(9) Draft report on the proposal for a directive of the European Parliament and of the Council amending Directives 2000/60/EC and 
2008/105/EC as regards priority substances in the field of water policy (17.07.2012). Proposer Richard Seeber, European Member 
of Parliament.
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effective, but this will still be expensive in terms of 
capital set up costs (10).
Measuring compliance with the low EQS for EE2 and 
E2 will also be a significant challenge. The techniques 
available to measure such very low levels of EE2 in 
natural waters and effluents are hardly routine. Some 
efforts have been made to develop more amenable 
enzyme‑linked immunoassay analysis methods but 
these have been fraught with issues around selectivity 
and sensitivity at the very low levels of detection 
required. This leaves both the water industry and 
regulators with a fundamental problem: it will be 
costly to remove EE2 to enable compliance with the 
target EQS, and costly to monitor and demonstrate 
legal compliance itself. So while it is technically 
possible to develop an EQS, in practice it may be 
very hard to implement. The widespread nature of 
contamination has only added to the problem: this 
is unlikely to be an issue in one isolated location, but 
one with significant cost implications across Europe 
and beyond. 
What other options might there be? Since EE2 is 
both the most potent of the steroid oestrogens 
and, seemingly, the most difficult to remove by 
conventional sewage treatment, could there be an 
argument for substituting this as the active ingredient 
in the contraceptive pill, leaving the remaining 
oestrogens to be removed conventionally at less cost? 
But what would replace it? If there were sufficient 
demand or need, the pharmaceutical industry could 
continue to provide women with access to birth 
control and reproductive choice while substantively 
altering the design of pharmaceuticals to protect the 
environment from unnecessary harm. This would 
represent a constructive precautionary approach (11). 
Is this option preferable?
13.7.2 Lesson 2: low-level pollutants with sublethal 
effects present fundamental issues for the 
precautionary principle
A number of definitions and interpretations of 
the precautionary principle exist (see Weiner 
and Rogers, 2002; Gee, 2006), of which the Rio 
Declaration (UN, 1992) is one that is widely cited:
'Where there are threats of serious or 
irreversible damage, lack of full scientific 
certainty shall not be used as a reason for 
postponing cost‑effective measures to prevent 
environmental degradation' (12).
The chapter on the precautionary principle (PP) in 
this volume, provides different definitions of the 
PP taken from other international treaties and the 
European Court of Justice, including the working 
definition proposed by the EEA which is designed to 
improve common understanding about the meaning 
and application of the PP. 
However, for this chapter it will be useful to consider 
the constituent parts of the Rio definition, the first 
of which deals with threats of serious or irreversible 
damage. 
It is not in dispute that intersex in fish represents 
both serious and irreversible damage to fish and 
that exposure to environmentally relevant levels 
of EE2 has adverse effects on fish reproduction, 
an ecologically relevant measure of impact. 
Uncertainties remain, particularly around fish 
population level effects, but the precautionary 
principle aims to promote action in the face of such 
uncertainties, when there is evidence of serious 
environmental damage that is irreversible. In fact, 
the level of scientific certainty concerning the 
risks (or threats) posed by oestrogens as mixtures 
to aquatic life, mediated through their endocrine 
disrupting effects is extremely high and there 
seems to be little or no doubt that there is sufficient 
evidence to justify applying the precautionary 
principle (Gross‑Sorokin et al., 2006). Responding 
to this evidence of harm, the water and chemical 
industries (and indeed some scientists) have 
increasingly asked the question, 'so what?' There 
may be male fish with eggs in their testes and this 
might be unpleasant, irreversible and widespread. 
But does it seriously damage fish populations? 
(Webb et al., 2003). Why pay potentially vast sums 
(10) It should be noted that some European countries have decided to clean up wastewater, even in the absence of regulation of EE2 
and E2, but in recognition of contamination of wastewater by pharmaceuticals, pesticides and endocrine disruptors. Full-scale 
treatments will be installed on more than 100 Swiss WWTP treating about 80 % of the Swiss municipal wastewater. The first 
full-scale ozonation plant will go in operation in Spring 2013 and will cost only 5 EUR/person/year including both capital and 
operational costs, because sand filtration already exists on this plant.
(11) There has been some research towards development of contraceptive formulations such as the progesterone-only pill, which do not 
contain oestrogen and instead target the female reproductive cycle more specifically (Lakha et al., 2007).
(12)  A European Commission Communication on the Precautionary Principle (EC, 2000) sets out guidance on when to apply the 
precautionary principle e.g. 'where there are reasonable grounds for concern'. The Communication sets out a set of general 
principles underpinning application of the PP This includes 'examining costs and benefits' which 'entails comparing the overall 
cost to the Community of action and lack of action, in both the short and long term. This is not simply an economic cost-benefit 
analysis: its scope is much broader, and includes non-economic considerations, such as the efficacy of possible options and their 
acceptability to the public' (p. 4). It also includes the need for the decision-making process to be 'transparent'.
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of money for risk management when the seriousness 
of such population — level effects is uncertain? 
These populations might collapse in the future, as 
indicated in the Great Lakes study of EE2 (Kidd 
et al., 2007), but maybe they will not. Is intersex an 
unpalatable but acceptable harm?
But even if the seriousness of the harmful threats 
is accepted, the precautionary principle's Achilles 
heel, however, as defined in the Rio Declaration, 
lies in the words 'cost effective'. The central issue 
for oestrogens (and quite possibly for many other 
chemicals that cause sublethal impacts at very low 
levels) is that any risk management measures are 
likely to be very costly, and as we have discussed 
above, this may be a price too high to pay.
The potentially high costs of risk management 
have combined with protracted debates about 
what constitutes acceptable harm to seriously 
delay decision‑making about the regulation of 
EE2 and other steroid oestrogens. This has been 
compounded by a precautionary principle whose 
definition includes issues of disproportionate 
cost and cost effectiveness, either explicitly or 
implicitly (13). Defined in this way the precautionary 
principle may be logical and rational, but it can also 
paradoxically become a perfect excuse for inaction 
or, at best, seriously delayed action. It is therefore 
perhaps no surprise that eight years after the 
UK government officially recognised EE2 and other 
steroid oestrogens as posing a risk to wildlife that 
should be managed, and some 30 years after the first 
observations of their effects in wild fish populations, 
that the regulation of EE2 is still undecided. And 
even if the EC proposal is agreed, it will not come 
into force until at least 2015.
Such long delays have, one might argue, been 
completely within the spirit of the precautionary 
principle at least as defined in the Rio declaration. 
The precautionary principle is well intended and 
should expedite decision‑making in the face of 
uncertainty. But in reality decision‑making has been 
painfully slow. We are left with the uncomfortable 
knowledge of a serious environmental issue that has 
been, and continues to be, unresolved: one which 
we may have to live with if the price of precaution is 
deemed too high. This is a bitter pill to swallow.
13.7.3 Lesson 3: the need for an open debate on 
precaution and decision-making 
Our environment is full of low‑level pollutants 
present as mixtures that cause sublethal effects. 
The European Inventory of Existing Commercial 
Chemical Substances (EINECS) lists over 
100 000 chemical compounds and little is known 
about the toxicity of about 75 % of them. Several 
hundred new substances are marketed each year after 
some basic premarket toxicity testing and these are 
registered in the European List of Notified Chemical 
Substances (ELINCS), which currently contains about 
2 000 chemicals. 
In 2007 the new chemicals EU regulation, REACH 
(Registration, Evaluation, Authorisation and 
restriction of CHemicals) was enacted. This 
reformed chemicals laws and set up procedures and 
responsibilities to address the backlog of untested 
chemicals, focusing on some 30 000 substances 
now being evaluated by industry and the new 
EU chemicals agency ECHA. Hazard identification 
and quantification is challenging however, and 
implementing monitoring programmes and 
conducting risk assessments for this whole 'chemicals 
universe' is unfeasible. Moreover, we do not have 
the tools to fully analyse how mixtures of these 
chemicals behave. The only logical way forward 
seems to be to reduce exposure as much as possible 
— to be precautionary. But this comes at a price 
and raises ethical questions of where responsibility 
should lie. Do we want the water industry to reduce 
exposure through costly treatment? Do we want the 
pharmaceutical industries to invest in developing 
new, less harmful contraceptive pills? Either way, are 
we as a society, prepared to pay for it? Do we care? 
The average fish in a stream or person in the street 
now has hundreds of novel compounds in their 
bodies that were not there 60 years ago. We can 
measure them in adult and foetal tissue. We know 
they have detrimental effects such as intersex in fish. 
We have changed the chemical environment of the 
developing organism. EE2 is a perfect case study 
of how we are responding as a society to difficult 
decisions regarding the need for, and challenges of, 
risk management for these low‑level pollutants with 
chronic sublethal effects. 
(13) The EU communication on the precautionary principle also recommends an 'Examination of the benefits and costs of action and lack 
of action'. This 'examination of the pros and cons should include an economic cost benefit analysis where this is appropriate and 
possible.However, such an 'examination of the pros and cons cannot be reduced to an economic cost-benefit analysis'. It is wider in 
scope and includes non-economic considerations (EC, 2000). The EEA working definition of the PP also uses the broader 'pros and 
cons' rather than 'costs and benefits' for similar reasons, including the importance of the non-quantifiable 'cons' such as the melt 
down of public trust in scientists and policticians which occurred in the BSE saga (see EEA, 2001, Ch. 15 on BSE).
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A key observation from this case study is that the 
public has been and continues to be silent witnesses. 
A key lesson learnt from previous case studies 
(EEA, 2001; Gee, 2006; Lokke, 2006) has been that 
the process of applying precaution must encourage 
public participation, such that the costs of action 
(e.g. risk management) and potential costs of inaction 
are debated. This enables value judgements and 
decisions to be made in an open and democratic 
way. Transparency of decision‑making and the need 
to involve all interested parties as early as possible 
is a central tenet of the European Commission 
communication on the precautionary principle 
(EC, 2000), which states that:
'All interested parties should be involved 
to the fullest extent possible in the study of 
various risk management options that may 
be envisaged once the results of the scientific 
evaluation and/or risk assessment are available.'
The US National Academy of Sciences has also 
repeatedly stressed the importance and need 
for stakeholder involvement at all stages of the 
risk‑based decision‑making process (NAS, 2009.) 
Prior to this, in 1998 the UK Royal Commission 
on Environmental Pollution published a report on 
Setting Environmental Standards (RCEP, 1998) in 
which it emphasised that decisions must be informed 
by an early understanding of peoples values, with 
a process that ensures transparency and openness. 
This is a view that is shared by the chemicals industry 
(Webb et al., 2003). 
The Royal Commission also identified specific 
mechanisms by which this could be achieved. It 
stated that those affected have a right to make 
their views known before a decision is made and 
that 'it is no longer acceptable for decisions to be 
negotiated privately between the regulator and 
polluter' (RCEP, 1998). This was fully endorsed 
by the UK government in their response to the 
Commission's report. But this endorsement is yet to 
translate into action. Opportunities for engagement 
and consultation that do exist are insufficient (14).
Decisions regarding regulation of EE2 and its sister 
oestrogens, and the dilemmas and issues these 
pose, have been, and continue to be undertaken 
in a poorly understood, closed process that has 
little engaged the public. It is vitally important 
that decision‑makers understand about the 
acceptability of risk, appetite for precaution and 
the willingness to pay for being precautionary. 
The views and concerns of the public have to 
date however gone largely undocumented. This 
is not an academic exercise: it is fundamental 
to making a decision on such a complex and 
potentially costly issue, a point emphasised by 
the Royal Commission in 1998 and the European 
Commission in 2000. Without public support the 
costs of risk management, of regulation of EE2, 
may be seen by policy makers as disproportionate. 
It might be that the weight of evidence suggests 
that public opinion is not on the side of risk 
management, that we are prepared to live with 
endocrine disruption in the environment as 
collateral damage associated with flexible fertility 
in our own species. But what is very clear is that 
without asking the public it will be far easier to 
come to a conclusion based largely on costs alone. 
This loads the dice before they are thrown. 
(14) For example in the development of the next round of River Basin Management Plans across the EU under the Water Framework 
Directive. 
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1938 17α-ethinyl estradiol (EE2) synthesised
1943 EE2 marketed as a contraceptive
1962–1969 USFDA approve the birth control pill and the United Kingdom allows it to be prescribed through its National Health 
Service
1970 Pill users increase in number from 50 000 to 1 million
1976 First speculation that oral contraceptives might pass through sewage treatment works (STWs) into the aquatic 
environment
1979 Kinloch Nelson and Bunge publish a study showing low sperm counts in 93 % of men about to undergo vasectomies
1982 Routine	health	checks	of	male	fish	(roach)	in	a	UK	river	show	the	presence	of	oocytes	in	testes	(intersex).	The	rate	
of hermaphroditism is very high in comparison to the norm
Mid-1980s First reports of contraceptive pill hormones in river water
1985 High	levels	of	female-specific	yolk	protein	(vitellogenin)	found	in	blood	of	male	fish	in	a	fish	farm	receiving	effluent	
containing river water
1985 Nonylphenols	discovered	in	sewage	effluents	and	in	sludge
1991 National	survey	shows	that	oestrogenic	effluents	are	widespread	in	England	and	Wales
1991 4-Nonylphenol is rediscovered as an oestrogen
1992 Meta-analysis of 61 studies shows sperm counts have declined 50 % in the preceding 50 years
1993 Theo Colborn and Clement publish 'The Wildlife Human Connection' suggesting widespread endocrine disrupting 
effects in wildlife and humans as a result of exposure to chemicals
1994–1996 Sharpe and Skakkebaek publish a hypothesis that testicular cancer, hypospadias, cryptorchidism and lowered semen 
quality are part of a syndrome caused by exposure to environmental oestrogens during foetal life
1993 BBC Horizon screens the award-winning documentary 'Assault on the male'
1995–1996 Surveys	show	that	intersex	is	widespread	in	roach	and	is	especially	prevalent	downstream	of	STWs	with	low	effluent	
dilution. Feminising syndromes in other wildlife species are reported
1996 Major European workshop on endocrine disruptors are held, jointly sponsored by the European Commission, the 
European	Environment	Agency,	the	European	Centre	for	Environment	and	Health	and	the	World	Health	Organization
1998 Steroid oestrogens, and EE2 in particular, are shown to be the most potent oestrogenically active substances in 
domestic	effluent
1998 Royal Commission on Environmental Pollution publishes a report Setting environmental standards, in which it 
emphasises that decisions must be informed by an early understanding of people's values. It is endorsed by the 
United Kingdom government
1999 European Union launches a Strategy on endocrine disrupters
2001 Feminisation is shown to be a permanent phenomenon that is progressive with age i.e. duration of exposure
2001 Schering publish a whole life-cycle study showing EE2 causing full sex reversal of males to females at concentrations 
> 2 ng/L
2002 Silva et al. show additive effects of oestrogenic endocrine disrupting chemicals in vitro: 'something from nothing'
2002-2003 More	widespread	surveys	show	intersex	fish	are	present	throughout	the	United	Kingdom.	Widespread	anti-
androgenic	activity	is	discovered	in	sewage	effluents
2003 Nonylphenol and nonyphenol ethoxylates are banned in the European Union as a hazard to human and 
environmental safety. Serious evaluations of other endocrine disruptors such as BPA take place
2004 Predicted No Effect Concentration (PNEC) of 0.1 ng/L derived for EE2
2004 UK	Endocrine	Disruption	Demonstration	Programme	commences,	evaluating	the	efficiency	of	removing	oestrogens	
from sewage treatment processes 
2007 Draft environmental quality standard for EE2 prepared by the Environment Agency of England and Wales
2008 Experimental	lakes	study	in	Canada	reports	a	population	crash	of	fish	after	exposure	to	EE2	at	6	ng/L
2009 UK	Demonstration	Programme	reports	first	phase	results	showing	difficulty	removing	EE2	to	the	PNEC	using	
conventional sewage treatment approaches
2012 European Commission publishes proposals to regulate EE2 as a 'Priority Substance' under the EU Water Framework 
Directive, which if accepted may come into force after 2015. An amendment to this proposal is tabled in July 2012 
which proposes delay of setting EQS until 2016, with the aim of meeting this by 2027'
Table 13�1 Early warnings and actions
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